Episode
Ozempic Just Got Cheap Enough to Change the Entire World
- Podcast
- Good Revenue News
- Published
- Mar 27, 2026
- Duration seconds
- 618
- Processing state
not_requested- Canonical source
- https://shows.acast.com/good-revenue/episodes/ozempic-boom-just-got-global-pricing-power-ai-targeting-to-r
Actions
POST https://stenobird.com/v1/public/podcasts/good-revenue-6621493/episodes/ozempic-just-got-cheap-enough-to-change-the-entire-world/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/good-revenue-6621493/ozempic-just-got-cheap-enough-to-change-the-entire-world.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
A blockbuster drug collapsing from $1,000 to $15 looks like a pricing story. It isn’t. It is a signal that control over human behavior, demand, and consumption is shifting fast. Between generics, new science, and AI-driven optimization, entire industries tied to addiction, food, and habit-driven spending may face structural decline. This episode breaks down why this disruption was inevitable and what happens next. CHAPTERS 00:00 $1,000 drug drops to $15 overnight 00:30 The real story behind the price collapse 00:56 Patent cliff and global generics surge 01:40 Pricing pressure spreads beyond India 02:30 Who controls the pipeline 03:40 New research changes expectations 05:20 AI enters dosing and drug discovery 06:30 This becomes an economic story 07:00 Workforce and GDP implications 08:15 Spending shifts across industries 09:15 What breaks next SOURCES - Affordable GLP-1 Options Emerging in India and Beyond (CNBC): https://www.cnbc.com/2026/03/23/novo-nordisk-cheap-weight-loss-drugs-india-generic-ozempic-wegovy-semaglutide.html - Global Impact of Ozempic Generics Expanding to China and Canada (NYT): https://www.nytimes.com/2026/03/19/health/ozempic-wegovy-generic-india-china-canada.html - Worldwide Reactions to Cheaper GLP-1 Drugs (BBC Analysis): https://www.bbc.com/news/articles/cx2g4411en3o - AI Optimizing Weight Loss Outcomes: https://www.sciencedirect.com/science/article/abs/pii/S2405457725003821 - Personalized Semaglutide Therapy with Artificial Intelligence: https://ai.jmir.org/2026/1/e86960 - Breakthroughs in GLP-1 Drug Engineering: https://www.sciencedirect.com/science/article/pii/S1359644625000467 - Cutting-Edge Ozempic Alternatives in Research: https://www.nature.com/articles/s41586-025-08683-y - Stanford Research on New Ozempic Rivals: https://med.stanford.edu…